TEO
TELECOM ARGENTINA SA
$13.37
+0.98%
$6.0B
No data for this timeframe.
Vol
Market Cap$6.0B
Cap SizeMid Cap
Analyst ConsensusSell (0%)
Inst. Holders4 funds
Inst. Value$8.4M
Inst. Activity1 buys / 2 sells
Insider Activity1B / 0S
Insider Net $$522.3K
Recent Activity
Jun 2, 2026
Insider
Urricelqui Alejandro Alberto bought 38,890 shares
Director @ $13.43 ($522.3K)
Inst.
MORGAN STANLEY — DOUBLED
576,229 shares ($6.7M)
Inst.
TWO SIGMA INVESTMENTS, LP — TRIM
116,495 shares ($1.4M)
Price Targets
$14.64
+4.4% upside
Hold
Current $14.02
Low $9.20
Median $15.00
High $19.00
5 analysts
$9.20
$19.00
Analyst Ratings
0Strong Buy
0Buy
2Hold
2Sell
2Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 9, 2026 | JP Morgan | MAINTAIN | Overweight → Overweight |
| May 27, 2026 | Scotiabank | MAINTAIN | Sector Underperform → Sector Underperform |
| Apr 29, 2026 | JP Morgan | UPGRADE | Neutral → Overweight |
| Mar 30, 2026 | Scotiabank | DOWNGRADE | Sector Perform → Sector Underperform |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.46 ▼ -23.6% | $0.34 — $0.57 | 251% YoY | 2 |
| Next Q | $0.31 ▲ +97.2% | $0.16 — $0.46 | 193% YoY | 2 |
| Current FY | $1.60 ▲ +23.1% | $1.04 — $2.06 | 669% YoY | 4 |
| Next FY | $1.57 ▲ +3.0% | $0.39 — $3.02 | -2% YoY | 4 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| MORGAN STANLEY | $6.7M | DOUBLED |
| TWO SIGMA INVESTMENTS, LP | $1.4M | TRIM |
| WELLS FARGO & COMPANY/MN | $189.1K | — |
| BANK OF AMERICA CORP | $152.9K | TRIM |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 2, 2026 | Urricelqui Alejandro | BUY | $522.3K |
4 institutional holders with $8.4M total value (722,183 shares) as of 2025-Q4. Top holders: MORGAN, TWO, WELLS. Net selling activity: 2 institutions trimmed/exited vs 1 added.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | MORGAN STANLEY | 576,229 | $6.7M | 79.8% | DOUBLED +257.3% |
| 2 | TWO SIGMA INVESTMENTS, LP | 116,495 | $1.4M | 16.1% | TRIM -42.9% |
| 3 | WELLS FARGO & COMPANY/MN | 16,288 | $189.1K | 2.3% | — |
| 4 | BANK OF AMERICA CORP /DE/ | 13,171 | $152.9K | 1.8% | TRIM -38.3% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | DOUBLED | 161,290 | 576,229 | +257.3% | $6.7M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 204,172 | 116,495 | -42.9% | $1.4M | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | TRIM | 21,342 | 13,171 | -38.3% | $152.9K | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 48,873 | 204,172 | +317.8% | $1.5M | 2025-Q3 |
| MORGAN STANLEY | TRIM | 429,230 | 161,290 | -62.4% | $1.2M | 2025-Q3 |
| MORGAN STANLEY | ADD | 314,512 | 429,230 | +36.5% | $3.8M | 2025-Q2 |
| UBS Group AG | ADD | 152,689 | 196,984 | +29.0% | $1.7M | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 13,896 | 48,873 | +251.7% | $431.5K | 2025-Q2 |
| UBS Group AG | TRIM | 206,132 | 152,689 | -25.9% | $1.6M | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | NEW | — | 13,896 | — | $141.6K | 2025-Q1 |
| MORGAN STANLEY | ADD | 201,980 | 318,254 | +57.6% | $4.0M | 2024-Q4 |
| UBS Group AG | DOUBLED | 23,466 | 206,132 | +778.4% | $2.6M | 2024-Q4 |
| CITADEL ADVISORS LLC | TRIM | 65,416 | 29,800 | -54.4% | $375.2K | 2024-Q4 |
1 unique insiders with 1 transactions. Net insider value: $522.3K ($522.3K bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 2, 2026 | Urricelqui Alejandro Alberto | Director | BUY | 38,890 | $13.43 | $522.3K |
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Sell (0% buy). Based on 6 analysts: 0 strong buy, 0 buy, 2 hold, 2 sell, 2 strong sell.
Analyst Price Targets
$14.64 mean target
+4.4% upside
Hold (2.40)
$9.20 Low
$19.00 High
| Metric | Value |
|---|---|
| Current Price | $14.02 |
| Target Low | $9.20 |
| Target Mean | $14.64 |
| Target Median | $15.00 |
| Target High | $19.00 |
| # Analysts | 5 |
| Recommendation | Hold (2.40) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.46 | $0.34 | $0.57 | 251.4% | -23.6% | — | $2.0B | 36.6% | 2 |
| Next Q 2026-09-30 |
$0.31 | $0.16 | $0.46 | 193.1% | +97.2% | — | $1.8B | 24.4% | 2 |
| Current FY 2026-12-31 |
$1.60 | $1.04 | $2.06 | 669.0% | +23.1% | 1↑ 1↓ | $6.8B | 14.7% | 4 |
| Next FY 2027-12-31 |
$1.57 | $0.39 | $3.02 | -2.1% | +3.0% | 1↑ 0↓ | $7.7B | 13.3% | 4 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.456 | |
| 7d ago | $0.571 | -0.115 |
| 30d ago | $0.597 | -0.141 |
| 60d ago | $0.571 | -0.115 |
| 90d ago | $0.571 | -0.115 |
2 analyst firms have rated this stock: 1 upgrades, 1 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 9, 2026 | JP Morgan | MAINTAIN | Overweight | Overweight |
| May 27, 2026 | Scotiabank | MAINTAIN | Sector Underperform | Sector Underperform |
| Apr 29, 2026 | JP Morgan | UPGRADE | Neutral | Overweight |
| Mar 30, 2026 | Scotiabank | DOWNGRADE | Sector Perform | Sector Underperform |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | 0 | 0 | 2 | 2 | 2 | 0% | |
| Mar 1, 2026 | 0 | 0 | 2 | 2 | 2 | 0% | |
| Feb 1, 2026 | 0 | 0 | 2 | 2 | 2 | 0% | |
| Jan 1, 2026 | 0 | 0 | 2 | 2 | 2 | 0% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.